Labostro, Justine Lyka .
HRN: 24-49-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2024
CEFUROXIME 500MG (TAB)
07/06/2024
07/12/2024
PO
500mg
BId
Nsvd
Waiting Final Action
07/09/2024
CEFUROXIME 1.5GM (VIAL)
07/09/2024
07/15/2024
IV
1.5g
Q8
Rmle
Waiting Final Action